FDG-PET联合静息心肌灌注显像在非肉芽肿性心肌炎中的诊断价值
FDG-PET灵敏度/特异度分别为61%/100%,静息心肌灌注显像为59%/71%,两者联合灵敏度82%、特异度71%。联合FDG-PET与静息心肌灌注显像或可同时捕捉炎症与纤维化成分,用于检测非肉芽肿性心肌炎。
要点
- FDG-PET诊断非肉芽肿性心肌炎特异度达100%,但灵敏度仅61%。
- FDG-PET联合静息心肌灌注显像可将灵敏度提升至82%。
- 静息心肌灌注显像灌注缺损与CMR晚期钆增强的空间一致性仅为中等。
核心结论
- 联合FDG-PET与静息心肌灌注显像或可捕捉炎症与纤维化成分,用于检测不同疾病阶段的非肉芽肿性心肌炎。
研究设计与样本
- 以心内膜心肌活检按共识标准确立诊断,否则以最终临床裁定诊断作为参考标准,所有患者PET后随访至少12个月。
主要发现
- FDG-PET灵敏度/特异度为61%/100%,静息心肌灌注显像为59%/71%。
- FDG-PET读者间一致性极好(κ=0.84,95%CI 0.62-1.00)。
- FDG-PET联合静息心肌灌注显像灵敏度82%(95%CI 50-93%)、特异度71%(95%CI 29-96%)。
- 晚期钆增强(排除孤立心内膜下模式)灵敏度/特异度为72%/57%,静息心肌灌注显像灌注缺损与晚期钆增强空间一致性中等(κ=0.35,95%CI 0.23-0.47)。
临床怎么用
- 对疑似非肉芽肿性心肌炎患者,可考虑FDG-PET联合静息心肌灌注显像作为无创影像评估选项。
- 联合显像高特异度有助于排除心肌炎,联合方案灵敏度提高但特异度仍有限。
局限性
- 联合方案特异度95%CI宽(29-96%),估计不精确。
- 部分患者缺乏心内膜心肌活检,参考标准依赖临床裁定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Data on the use of fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) in non-granulomatous myocarditis are limited, and no study has evaluated the diagnostic performance of combined FDG-PET and rest myocardial perfusion imaging (rMPI). METHODS: We conducted a multicenter prospective observational feasibility study of patients who underwent combined FDG-PET/CT with rMPI as well as cardiac magnetic resonance (CMR) for suspected myocarditis. When available, endomyocardial biopsy (EMB) established the diagnosis according to consensus criteria. Otherwise, the final adjudicated clinical diagnosis served as the reference standard. All patients had a minimum follow-up of 12 months following PET imaging. RESULTS: Twenty-five patients were included, of whom 18 (72%) were diagnosed with myocarditis. FDG-PET and rMPI demonstrated a sensitivity/specificity of 61%/100%, and 59%/71%, respectively. Inter-reader agreement for FDG-PET was excellent (κ = 0.84, 95% CI 0.62-1.00). The combination of FDG-PET and rMPI yielded a sensitivity of 82% (95% CI: 50-93%) and a specificity of 71% (95% CI: 29-96%). Late gadolinium enhancement (LGE), excluding isolated subendocardial patterns, showed a sensitivity/specificity of 72%/57%. Spatial agreement between rMPI perfusion defects and LGE on CMR was modest (κ = 0.35, 95%CI: 0.23-0.47). CONCLUSION: Combining FDG-PET with rMPI may be a feasible imaging modality for detecting non-granulomatous myocarditis by capturing both inflammatory and fibrotic components across different disease stages.
引用
- Lucinian YA, Martineau P, Harel F, et al. 18F-fluorodeoxyglucose positron emission tomography and rest myocardial perfusion imaging in non-granulomatous myocarditis. Eur J Nucl Med Mol Imaging. 2026. PMID: 42191946. doi:10.1007/s00259-026-07960-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。